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Abstract
Objectives To: (1) compare prevalence of diagnosed,
measured, total and undiagnosed hypertension among late
middle-aged adults in the United States of America and
Ireland; (2) identify the most important predictors of
hypertension and compare them across the two countries;
(3) investigate whether cross-national differences in prev-
alence rates are explained by country differences in
behavioural risk factors.
Methods We use data from the 2008 and 2010 waves of
the Health and Retirement Study (n = 1,938) and the first
wave (2009/2011) of The Irish Longitudinal Study on
Ageing (n = 1,455). We employ probit models to deter-
mine whether individual attributes, socioeconomic
characteristics and behavioural health factors, including
smoking, alcohol consumption and obesity, are associated
with hypertension. We do not consider whether respon-
dents are on antihypertensive medication.
Results Prevalence of diagnosed hypertension is higher in
the United States of America (48.6 versus 32.4 %).
Prevalence of undiagnosed hypertension is higher in Ire-
land (41.2 versus 19.7 %). Little of the difference in
prevalence rates is explained by country differences in
behavioural risk factors.
Conclusions A greater focus on prevention of high blood
pressure is necessary in Ireland.
Keywords Hypertension  Diagnosed  Measured 
Undiagnosed  Ireland  USA
Introduction
Hypertension, also known as high blood pressure, is one of
the most common chronic conditions worldwide. Even
more important, hypertension is an important risk factor for
more serious conditions that carry greater risk of disability
and death, primarily cardio- and cerebro-vascular events,
and is the single most important modifiable risk factor for
stroke and myocardial infarction in both developed and
developing countries (Kearney et al. 2005). Hypertension
already affects one billion people worldwide and is a global
health issue (WHO 2013).
In many population studies with a focus or a component
on health, hypertension prevalence rates are derived from
‘self-reports’: respondents are asked to report whether they
have hypertension at present and/or have ever been diag-
nosed with hypertension. Prevalence based on self-reports
might, however, seriously underestimate the actual preva-
lence. This is because moderate, and even high levels of
high blood pressure are typically asymptomatic and rates of
undiagnosed or undetected hypertension are generally high
(WHO 2013).
A way to assess the extent to which hypertension is
undiagnosed is to collect both self-reported and objective
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measures for the same respondents. This is, however, rarely
done in population studies. Also, international comparisons
of prevalence rates are difficult, as surveys often differ in
their methodology and design and survey data for hyper-
tension are difficult to standardize.
Few studies have compared prevalence rates among
middle-aged and older adults across Europe and the United
States of America (USA). In a widely cited paper, Banks
et al. (2006) found that prevalence of both measured and
self-reported hypertension among middle-aged adults is
higher in the USA than in England. Using data on indi-
viduals aged 35–74 from six European countries, Canada
and the USA, Wolf-Maier et al. (2003) found that preva-
lence of measured hypertension is higher in Europe.
Crimmins et al. (2011) analysed data on adults aged 50?
from 11 European countries, England and the USA and
found higher prevalence of self-reported hypertension in
the USA. Higher rates of hypertension control and treat-
ment were also found in the USA as compared to Western
Europe (Wang et al. 2007; Wolf-Maier et al. 2004). None
of these studies, however, used data from Ireland.
Prompted by the study by Banks et al. (2006), Savva
et al. (2013) compared hypertension prevalence among
adults aged 50? across England, the USA and Ireland.
Focusing on the American-Irish comparison, the authors
found that while prevalence of self-reported hypertension
is higher in the USA, prevalence of measured hypertension
is higher in Ireland. As a formal investigation of why dif-
ferences exist between the two countries was not carried
out in this study, we attempt to fill this gap and have three
aims.
Our first aim is to compare prevalence of diagnosed,
measured, total and undiagnosed hypertension in the USA
and Ireland, using recent data designed to provide com-
parable information across nationally representative
samples of community-dwelling older populations in the
two countries. Our second aim is to identify the most
important factors leading to higher probability of diag-
nosed, measured, total and undiagnosed hypertension and
to compare them across the two countries. Our third aim is
to investigate whether and the extent to which cross-
national differences in prevalence rates are explained by
country differences in behavioural risk factors.
It is worth noting that the USA is one of the first
countries to have embarked on national hypertension pre-
vention and control programmes. The blood pressure
education programme was established in 1972 (NHLBI
2014) and, since then, the USA has had one of the world’s
highest rates of hypertension awareness, treatment and
control (Joffres et al. 2013; Egan et al. 2010). Cardiovas-
cular disease remains, however, the single largest cause of
death in the USA, accounting for 25 % of all deaths in
2008 (Pagidipati and Gaziano 2013). In Ireland, the first
cardiovascular health policy framework was introduced in
1999 and a second framework followed in 2010 (DOHC
1999, 2010). Despite improvements in death rates from
cardiovascular disease, cardiovascular disease remains the
single largest cause of death also in Ireland and accounted
for 35 % of all deaths in 2008 (DOHC 2010).
Methods
Data
For the USA, we use data from the Health and Retirement
Survey (HRS), which is a biennial, population-representa-
tive, longitudinal study of the economic, health and social
status of older Americans. It was launched in 1992 and
initially recruited a sample of more than 12,000 non-in-
stitutionalised individuals aged 50?. Respondents were
recruited from a multistage area probability sample of
households, with oversamples of Blacks, Hispanics, and
residents from the state of Florida (Heeringa and Connor
1995; Juster and Suzman 1995). Respondents have since
been followed up regularly with supplementary samples
added at various waves.
For our analysis, we use the RAND HRS Data file,
which is a user-friendly dataset based on the HRS data. It
was prepared by the RAND Center for the Study of Aging
with funding from the National Institute on Aging and the
Social Security Administration. We use pooled data from
the 2008 and 2010 interviews, when blood pressure mea-
surements in randomly selected subsamples of the study
population were collected (RAND HRS Data, Version L
2011a; RAND HRS Data, Version M 2011b).
For Ireland, we use data from The Irish Longitudinal
Study on Ageing (TILDA), which is a biennial, population-
representative, longitudinal study of community-dwelling
adults aged 50? residing in Ireland. The survey instrument
was developed based on best international practice and
harmonized with other large cohort studies of ageing,
including HRS.
For our analysis, we use the first wave of TILDA, which
was collected between October 2009 and July 2011. As
explained in detail by Savva et al. (2013) and McGarrigle
et al. (2014), the baseline sample was recruited from a
clustered random sample of all households in Ireland. A
total of 8,504 respondents (8,175 aged 50? and 329
younger spouses/partners of eligible individuals) com-
pleted a computer-assisted personal interview (CAPI) in
their home. Information on various aspects of the respon-
dents’ lives, including the economic dimension, health
aspects and the social domain, was collected.
Each respondent was also invited to travel to one of two
health centres for a comprehensive health assessment,
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which was carried out by trained and qualified nurses.
Respondents who were unable or unwilling to attend a
health centre were offered a modified and partial assess-
ment in their own home. The availability of home-based
health assessments mitigated much of the potential selec-
tion bias associated with the need to travel to a health
centre (Savva et al. 2013). Among other clinical parame-
ters, cardiovascular measures were assessed and collated. A
total of 5,898 respondents underwent an assessment:
85.4 % in the health assessment and 15.6 % in their own
home. The overall response rate to the study was 62 %.
To ensure that hypertension prevalence rates are not
confounded by age, we follow Banks et al. (2006) and limit
the HRS-TILDA comparisons to those aged 57–64. Within
this age span, the average age of both samples is identical.
To ensure that differences between countries are not due to
special issues that exist in the Black or Hispanic commu-
nities in the USA, we restrict the American sample to non-
Hispanic Whites (Banks et al. 2010; Langa et al. 2009).
Although information on ethnic group is not collected in
TILDA, respondents are asked about their country of birth.
Around 92 % of respondents were born in Ireland. Of those
born elsewhere, 8 in 10 were born in Great Britain. We
exclude from the TILDA sample respondents born in
countries in which the population is predominantly non-
White. The final sample sizes are 1,455 for TILDA and
1,938 for HRS.
Measures of hypertension prevalence
Diagnosed
Both HRS and TILDA collect data on individual self-
reports of specific conditions with the general question:
‘‘Has the doctor ever told you have…?’’. We classify
respondents as having ‘‘diagnosed hypertension’’ if they
report hypertension among the conditions.
Measured
The key advantage in using data collected in HRS and
TILDA is that blood pressure is measured in both surveys.
Details on how blood pressure measurements are taken in
the two surveys can be found elsewhere (Cronin et al.
2011; Crimmins et al. 2008). Briefly, in HRS, three mea-
surements are taken by trained and qualified interviewers in
the respondent’s home. Measurements are taken 45–60 s
apart with the respondent seated. An Omron HEM-780
intellisense automated blood pressure monitor with ComFit
cuff is used. In TILDA, three separate readings are taken
1 min apart by trained and qualified nurses, either in a
dedicated health assessment or in the respondent’s home.
The first two measurements are taken with the respondent
seated and the third immediately after the respondent
stands up. An OmronTM digital automatic blood pressure
monitor with arm cuff (Model M10-IT) is used.
We create a binary variable for measured hypertension
based on the mean value of the first and second readings.
We classify respondents as hypertensive if: systolic blood
pressure (SBP) C140 mmHg and/or diastolic blood pres-
sure (DBP) C90 mmHg (Mancia et al. 2007; NHLBI
2004).
Total
The total measure codes respondents as hypertensive if
either they self-report to be hypertensive and/or have a
blood pressure value above the diagnostic threshold, which
is SBP C140 mmHg and/or DBP C90 mmHg.
Undiagnosed
We classify respondents as having ‘‘undiagnosed hyper-
tension’’ if they do not report having been told by a doctor
that they have hypertension but are hypertensive according
to the more comprehensive total prevalence measure. Put
differently, the prevalence of undiagnosed hypertension is
the fraction of total prevalence that is not diagnosed.
Control variables
We include age, gender and marital status as individual
attributes. We use two measures of socioeconomic status:
level of education and household income. To measure
education, we use the International Standard Classifica-
tion of Education (ISCED 97), which is a cross-national
classification framework for harmonising educational pro-
grammes and qualifications (UNESCO 1997). We identify
two groups: ISCED 0–3 (pre-primary, primary, lower sec-
ondary and upper secondary education); and ISCED 4?
(post-secondary non-tertiary or tertiary education).
Turning to income, for the USA we use data from
RAND Income and Wealth Imputation file, produced by
RAND Centre for the Study of Ageing (RAND 2011a, b).
In this file, single imputation techniques are used to derive
all components of income and household income is cal-
culated by aggregating income across the respondent and
her spouse if the respondent is married. For Ireland, we use
information from a single comprehensive question about
income across all household members. We correct house-
hold income by dividing it by the square root of the number
of persons in the household (Buhmann et al. 1988;
Avendano and Glymour 2008; Avendano et al. 2009; Hu-
isman et al. 2003; Sarang et al. 2012). Finally, we assign
individuals into income terciles, which are determined for
each country and each wave separately.
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HRS and TILDA collect information on several health-
related behaviours and respondents are asked whether they:
have ever smoked tobacco; smoke at present; and drink
alcohol. We identify three categories for smoking: current
smoker, past smoker and never smoked; and two categories
for alcohol consumption: current drinker and abstainer.
Both surveys also collect objective measures of body mass
index (BMI), which is the ratio of weight in kilograms to
height in meters squared. Height and weight are measured
during the enhanced face-to-face visit in HRS and during
the health assessment in TILDA. We use BMI to identify
whether respondents are obese (BMI C 30), overweight
(BMI C 25 and\ 30) or underweight/normal (BMI \ 25).
We separate obese individuals into three subgroups: class 1
(C30 and \35), class 2 (C35 and \40) and class 3 (C40).
We also include a variable meant to capture the extent of
contact with the medical system. For HRS, we include a
dichotomous variable equal to one if the respondent has had
outpatient surgery, has stayed in an hospital overnight or
has talked to a medical doctor about her health, including
emergency room, clinic visits or house calls, at least once in
the 2 years prior to the interview. For TILDA, we include a
dichotomous variable equal to one if the respondent has
visited a general practitioner, a hospital emergency
department, a hospital as outpatient or a hospital overnight
at least once in the year prior to the interview.
Although other risk factors might be important, due to
the comparative nature of our research, we only use those
comparably measured in both countries.
Statistical methods
We use unweighted probit models of determinants of
diagnosed, measured, total and undiagnosed hypertension
prevalence. We use STATA 12 to perform the analyses
(StataCorp 2011) and set a prior level of significance at
p \ 0.05. For ease of interpretation, we convert parameter
estimates to estimates of average marginal effects (AMEs).
Marginal effects are a popular means by which the effects
of variables in nonlinear models can be made more intui-
tively meaningful (Williams 2012). To illustrate, the AME
of a categorical variable is the mean change in the pre-
dicted probability that the outcome is equal to one as the
categorical variable changes from 0 to 1, holding all other
covariates at their observed values.
Results
Baseline characteristics
Table 1 lists the prevalence of diagnosed, measured, total
and undiagnosed hypertension. The results of statistical
tests for country differences are also displayed.
Prevalence of diagnosed hypertension is higher in the
USA. Prevalence of measured and undiagnosed hyperten-
sion is higher in Ireland. Total prevalence is higher in the
USA.
Table 1 also documents levels in prominent hyperten-
sion risk factors. The most striking differences are that
class 2 and class 3 obesity are significantly higher in the
USA and drinking is higher in Ireland.
Table 1 Hypertension prevalence rates and hypertension risk factors
in the USA (2008/2010) and Ireland (2009/2011): 57–64 years old
USA Ireland
Hypertension prevalencea
Diagnosed 48.6 32.4***
Measured 30.0 39.5***
Total 60.6 55.2**
Undiagnosed 19.7 41.2***
Individual characteristics
Age, mean 60.4 60.4
Male 42.8 45.9
Married 74.4 76.2
Behavioural health
Smoking
Never smoked 45.0 45.4
Past smoker 38.6 39.2
Current smoker 16.3 15.4
Drinking
Current drinker 64.5 82.7***
BMI category
Under/normal weight 20.8 21.2
Overweight 35.5 44.4***
Obese class 1 26.2 24.7
Obese class 2 11.5 7.1***
Obese class 3 5.9 2.6***
1? contact with medical system 95.2 88.4***
Socioeconomic gradient
Education
ISCED 4? 40.6 35.1**
Adjusted household income
First tercile 34.2 34.2
Second tercile 33.1 34.5
Third tercile 32.7 31.3
N 1,938 1,455
BMI body mass index, ISCED International Standard Classification of
Education
* p \ 0.05, ** p \ 0.01, *** p \ 0.001
a Diagnosed prevalence, whether a doctor told the respondent that
they were hypertensive; measured prevalence, SBP C 140 mmHg
and/or DBP C 90 mmHg; total prevalence, either self-report or
measured; undiagnosed prevalence, the fraction of total prevalence
that is not diagnosed
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Predictors of hypertension prevalence
and between-country comparisons
Table 2 lists estimates of probit models for diagnosed,
measured, total and undiagnosed hypertension prevalence
in the USA and Ireland. The purpose of these models is
twofold. The first is to identify the most important factors
leading to higher probability of diagnosed, measured, total
and undiagnosed hypertension, and the second is to com-
pare them across the two countries.
In both countries, obesity and contact with the medical
system are positively associated with the probability of
hypertension diagnosis (Columns 1 and 2). The probability
of having high blood pressure objectively is higher for
individuals who are men and obese (Columns 3 and 4). The
probability of being hypertensive based on the more
comprehensive total measure is higher for individuals who
are older, men and overweight or obese, with the estimated
obesity impact being much larger than overweight (Col-
umns 5 and 6). The most important predictors of
undiagnosed hypertension are absence of contact with the
medical system in the recent past and normal weight
(Columns 7 and 8).
A number of differences in the sign or significance of
hypertension risk factors across the two countries also
emerge. Most notably, older adults and men are more likely
to be diagnosed in USA, but not in Ireland. Men are more
likely to be undiagnosed in Ireland, but not in the USA.
Also, married adults are less likely to have high blood
pressure objectively in the USA, but not in Ireland.
Do differences in risk factors explain between-country
differences in prevalence rates?
Table 1 showed that prevalence rates of diagnosed and
undiagnosed hypertension in the USA are 48.6 and 19.7 %,
respectively. These compare to 32.4 and 41.2 % in Ireland.
We now use the models of Table 2 to simulate what the
prevalence rates of diagnosed and undiagnosed hyperten-
sion in Ireland would be if Irish individuals had the same
level of behavioural risk factors (drinking, smoking,
obesity and contact with medical system) as the average
American in this age group. In this simulation, we find that
risk-factor adjusted prevalence rates of diagnosed and
undiagnosed hypertension in Ireland would be 36.2 and
36.3 %, respectively.
By comparing the unadjusted and adjusted prevalence
rates, we can understand how much of the between-country
difference in hypertension prevalence is due to different
levels of behavioural risk factors. This comparison shows
that only around one-fourth [(36.2–32.4 %)/(48.6–32.4 %)]
of the difference in prevalence of diagnosed hypertension
is due to differences in this subset of behavioural risk
factors. Similarly, only less than one-fourth of the differ-
ence in prevalence of undiagnosed hypertension is
explained by differences in risk factors.
Discussion
Cross-national comparisons of health outcomes are rising
in importance as a method of addressing key questions in
international public health and of gaining insight into the
complex determinants of health. In this paper, we took
advantage of the comparability built into the design of the
Health and Retirement Study and The Irish Longitudinal
Study on Ageing to compare prevalence of diagnosed,
measured, total and undiagnosed hypertension among late
middle-aged adults across the USA and Ireland. We also
identified and compared the most important predictors of
hypertension and investigated how much of the cross-
national differences in prevalence rates are explained by
country differences in behavioural risk factors. It is worth
noting that cardiovascular disease remains the single larg-
est cause of death in both Ireland and the USA. Both
countries have also adopted hypertension prevention
strategies, although these have been in place for much
longer in the USA.
Our results show that, based on the more comprehensive
total measure that combines diagnosed and measured
hypertension, prevalence of hypertension is higher in the
USA. There exist, however, remarkable differences in
prevalence of diagnosed, measured and undiagnosed
hypertension. While prevalence of diagnosed hypertension
is higher in the USA, prevalence of measured and undi-
agnosed hypertension is higher in Ireland. Our findings are
in line with those of Wolf-Maier et al. (2003), Crimmins
et al. (2011) and Savva et al. (2013), as they confirm higher
prevalence of self-reported hypertension in the USA as
opposed to higher rates of measured hypertension in Ire-
land/Europe.
Turning to the predictors of hypertension prevalence,
three results stand out.
First, in both countries obesity is positively associated
with diagnosed, measured and total hypertension and
negatively associated with undiagnosed hypertension.
Second, in both countries, ‘contact with the medical
system’ is positively associated with the probability of
being diagnosed and negatively associated with the prob-
ability of being undiagnosed. The interpretation of this
finding is, however, problematic. It might be that more
frequent visits provide added opportunity for physicians to
detect undiagnosed hypertension, or the causality might be
reversed, and those who have already been diagnosed make
more visits to refill prescriptions or monitor treatment
effectiveness.
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Third, in both countries men are more likely to have
high blood pressure objectively and to be hypertensive
when the most comprehensive definition of hypertension is
used. Compared to their female counterparts, however,
men are more likely to be diagnosed in the USA and to be
undiagnosed in Ireland.
Turning finally to the role of behavioural risk factors in
explaining cross-national differences in prevalence rates, we
find that, even if the Irish had the same level of behavioural
risk factors as the average American in this age group, this
would explain around one quarter of the difference in prev-
alence of diagnosed and undiagnosed hypertension.
The question remains as to why such large discrepancies
exist in prevalence rates across the two countries.
One hypothesis behind higher rates of diagnosed
hypertension in the USA is that protocols and thresholds
for hypertension diagnosis may differ between the two
countries so that a similarly ill patient is diagnosed with
hypertension in the USA but not in Ireland. For guidance
on blood pressure measurement and hypertension diagno-
sis, the USA follows the Seventh Report of the Joint
National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure (NHLBI 2004)
whereas Ireland follows the European Society of Cardiol-
ogy (ESC) 2007 Guidelines for Cardiovascular Disease
Prevention (Mancia et al. 2007). These guidelines are,
however, generally similar. Another hypothesis behind
higher rates of diagnosed hypertension in the USA is that
the language by which physicians communicate health
problems to their patients may differ across the two
countries. Also, although we control for ‘quantity’ of
contacts with the medical system in the empirical model,
we have no information on the ‘quality’ of these contacts
and, again, this may differ among the two countries.
Overall differences in the clinical systems, community
programmes and environmental and policy support are
likely to be important factors behind the cross-national
differences in hypertension prevalence rates.
As rates of measured hypertension are considerably
higher in Ireland, we reflect on whether differences in
protocols for blood pressure measurements in HRS and
TILDA may be responsible. In particular, as for most
TILDA respondents blood pressure is measured in a ded-
icated health assessment, higher rates of measured
hypertension may be explained by the so-called ‘white coat
effect’, which is higher than normal blood pressure values
when measured in a medical environment (Mancia et al.
2007; Pickering et al. 1999). We investigate this hypothesis
by comparing blood pressure readings for TILDA respon-
dents who underwent a health assessment in their own
home as opposed to a dedicated health assessment. We find
no evidence that, ceteris paribus, significant differences in
blood pressure readings exist among the two groups.
Our findings should be considered in the context of
several limitations.
First, as all data analyses are cross-sectional, we inves-
tigate associations and are unable to confidently identify
the causes of differences in prevalence rates among the two
countries.
Second, the results on prevalence of measured hyper-
tension need to be interpreted with caution, for a number of
reasons. In both studies, prevalence of measured hyper-
tension is determined based on measurements carried out
on a single day and not on multiple measurements taken on
two or more occasions over a period of time as suggested
by the ESC Guidelines for Cardiovascular Disease Pre-
vention (Mancia et al. 2007). While important, this
limitation applies to all studies based on data from HRS
and its ‘sister’ studies and to a number of other interna-
tional studies (for example, see Kaur et al. 2012; Laaser
et al. 2012; Ploubidis et al. 2013). Also, as the third blood
pressure measurement in TILDA is taken after the
respondent stands up, we use the average of the first two
measurements, which are taken with the respondent seated
in both studies. Because of the so-called ‘white collar
effect’, the use of the first two readings might lead to a
possible overestimation of hypertension prevalence in both
countries. Finally, we do not distinguish between respon-
dents who are on antihypertensive medication and are
untreated. This is because a comprehensive list of pre-
scription medications obtained by direct observation of the
interviewer is collated in TILDA, but not in HRS.
Third, the list of comparably measured behavioural risk
factors and individual attributes is incomplete and a fuller
set may offer additional explanatory power. For example,
we do not include dietary patterns, as they are not mea-
sured in either study. We cannot exclude that a greater
proportion of the cross-national differential in prevalence
rates could have been explained had a more extensive list
of behavioural risk factors been used.
Fourth, we do not take into account past differences in
risk factors, but these may be partially underlying observed
differences in prevalence rates. For example, only in recent
years the obesity epidemic has hit Ireland where prevalence
of obesity rose from 11 to 25 % between 1998 and 2008,
compared to an increase from 20 to 32 % in the USA in the
same period (WHO 2012).
Fifth, some differences exist in the phrasing of the
questions posed to respondents. To illustrate, retrospective
information on frequency of contact with the medical
system is collected for the year prior to the interview in
TILDA, compared to 2 years, which is since the last
interview, in HRS.
Despite these limitations, it is noteworthy that this study is
unique in using recent data designed to provide comparable
information on health outcomes across nationally
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representative samples of community-dwelling older popu-
lations in Ireland and the USA. As international
comparability with HRS was an important consideration in
the design of TILDA, the methods used in the two studies are
remarkably similar.
In conclusion, our results indicate that prevalence of
measured and undiagnosed hypertension among late mid-
dle-aged adults is considerably higher in Ireland than in the
USA and that much of this difference is not explained by
conventional risk factors. Our results suggest that a greater
focus on prevention of high blood pressure is necessary in
Ireland.
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